# Bio-Thera Solutions

Source: https://onco.cc/companies/bio-thera-solutions/  
OnCo record `bio-thera-solutions` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Bio-Thera Solutions is a China-based pharmaceutical company running 3 late-stage cancer trials of BAT8008, BAT1308 and BAT8010 in cervical cancer.

## Summary

Bio-Thera Solutions, based in Guangzhou, China, is a pharmaceutical company. Bio-Thera Solutions is a Guangzhou-based biopharmaceutical company that develops and markets antibody therapeutics, including approved biosimilars and pipeline candidates for cancer and autoimmune disease. On ClinicalTrials.gov it is the lead sponsor of 3 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3), testing BAT8008, BAT1308, BAT8010 and BAT1006 in cervical cancer. The largest, NCT06123884 (BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer), plans to enrol 526 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Tags: ctgov-sponsor
- HQ: Guangzhou
- Type: pharma
- Website: https://www.bio-thera.com

## Sources

- Official website: https://www.bio-thera.com
- ClinicalTrials.gov: trials led by Bio-Thera Solutions: https://clinicaltrials.gov/search?lead=Bio-Thera%20Solutions
- Pipeline page: https://www.bio-thera.com/col_16/

## Connected records

- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/)
- drugs: [Bevacizumab](https://onco.cc/drugs/bevacizumab/)
- trials: [A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors](https://onco.cc/trials/nct06341114/), [A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors](https://onco.cc/trials/nct06376136/), [BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer](https://onco.cc/trials/nct06123884/)

---
JSON: https://onco.cc/api/v1/entities/bio-thera-solutions.json